Managing Diabetes in Software Freedom
14 days ago
- #Software Freedom
- #FOSS
- #Diabetes Management
- The author was diagnosed with early-stage Type 2 Diabetes in March 2025.
- A diabetes specialist recommended using a Continuous Glucose Monitor (CGM) and proprietary app, Freestyle Libre, which raised software freedom concerns.
- The author refused to use the proprietary app due to restrictive terms and data collection policies.
- Discovered a FOSS alternative, Juggluco, which worked effectively with the CGM device.
- Juggluco provided better reporting features than the proprietary Abbott app, according to the specialist.
- The author plans to contribute to Juggluco and help get it listed on F-Droid.
- Abbott attempted to remove Juggluco from Google's Play Store, citing false claims about proprietary libraries.
- The experience highlights the importance of software freedom in medical technology.
- The author encourages support for SFC to continue this and other work in 2026.